Hatteras Venture Partners

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.

BiotechHealthtechMenlo Park, US

Joseph S. Zakrzewski(Co-Founder & Director)EEEric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)SCSanjay Chanda(Chief Development Officer)inLOLucy O. Day(Chief Financial Officer)in

Co-investorsADAdjuvant CapitalBIBioRock VenturesFLFlucas VenturesMOMountain Group CapitalRARA CapitalBIBiotechnology Value Fund

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

CPCraig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)KHKevin Hykes(President, Chief Executive Officer & Director)in

Co-investorsABABS VenturesNENew Enterprise Associates (NEA)TRTreo Ventures, LlcWIWindham Capital PartnersYSYsios CapitalACAction Potential Venture Capital Ltd.+1 more

Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.

BiotechDeep TechHealthtech

NMNello Mainolfi(Founder)inBBBruce Booth(Chair)in

Co-investorsATAtlas VentureAVAvoro Capital AdvisorsBABain Capital Life SciencesBEBessemer Venture PartnersMRMRL Ventures FundNENextech Invest+6 more

Shattuck Labs is a biotechnology company developing biologic medicines targeting TNF receptors, including the TL1A/DR3 axis, for patients with cancer and inflammatory or life-altering diseases.

BiotechHealthtechAustin, US

JHJosiah Hornblower(President/CEO)inTaylor(Co-founder & Chief Executive Officer, Board Member)

BoardWalter Loewenbaum(Director)

Co-investorsECEcoR1 CapitalOROrbiMedREREDMILET.T. Rowe Price

A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types.

BiotechDigital HealthMedical DevicesDurham, US

CMCharles M. Perou(Founder and Director)inMMMICHAEL MILBURN(Executive Officer, Director)inDavid Neil Hayes(Executive Officer, Director)

BoardArnold Levine(Director)

Board seatMLMyla Lai-GoldmanClay Thorp· per SEC Form D

Co-investorsIAIAG Capital Partners

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.

BiotechHealthtechMedical DevicesRaleigh, US

Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)JFJohn Fahy(Director)in

BoardCSChristy Shaffer(Director)inRishi Gupta(Director)inTSTim Shannon(Director)in

Co-investorsOROrbiMedCACanaan PartnersPAPappas Capital

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

LELynn Elliott(Co-Founder)MJMudit Jain(Co-Founder)PMPaul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)KPKetan Patel(Director)in

Co-investorsTRTreo Ventures, LlcF-F-Prime Capital

Boomerang Medical develops a bioelectric neuromodulation device to treat bowel urgency symptoms in patients with ulcerative colitis and other inflammatory bowel disease.

BiotechDigital HealthMedical DevicesMountain View, US

Co-investorsARArboretum Ventures

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.

HardwareHealthtechMedical DevicesRaleigh, US

RSRavish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)

Co-investorsLILightstone VenturesAMAmzak HealthMOMountain Group CapitalUSUS Venture Partners

Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.

BiotechDigital HealthChapel Hill, US

Jenny Ting(Director and Co-founder)Anil Goyal(CEO and Director)

Co-investorsDEDelin VenturesOSOsage University PartnersOUOUP (Osage University Partners)

iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases.

BiotechHealthtechMedical DevicesMinneapolis, US

MKMudit K. Jain(Co-Founder and Chairman of the Board)LELynn Elliott(Co-Founder and Director)inSMSteve Masson(President & CEO)in

Co-investorsTRTreo Ventures, LlcF-F-Prime Capital

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

DEDavid Eveleth(Executive Officer, Director)inSNSchalon Newton(Executive Officer)in

BoardCSChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsEXExSight VenturesSOSolasta VenturesACAccess BiotechnologyBIBios PartnersCOCorrelation VenturesFEFemHealth Ventures+1 more

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.

AI & Machine LearningDigital HealthHealthtechBranford, US

Joshua Ransom(Executive Officer)DLDavid Levin(Chief Executive Officer)inJBJosh Brown(Chief Technology Officer)inSCScott Caflisch(Chief Information Security Officer)inJGJeff Graham(Chief Data Officer)inJSJennifer Stacey(Chief Operating Officer)in

Board seatJohn Crumpler· per SEC Form D

Co-investorsCOConnecticut InnovationsEXExcelerate Health VenturesMAMartin VenturesBOBoston Millennia Partners

Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.

AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US

OIOmer Inan(Co-founder, Chief Scientific Officer)inACAndrew Carek(Co-founder, Chief Technical Officer)inAGAmit Gupta(Co-founder, Advisor)inMEMozziyar Etemadi(Co-founder, Head of AI)OIOmer Inan, PhD(Co-founder, Chief Scientific Officer)inACAndrew Carek, PhD(Co-founder, Chief Technical Officer)in

Board seatLPLauren Pierce Flickinger· per SEC Form D

Co-investorsBABayMed Venture PartnersBRBroadview VenturesCRCross-Border Impact VenturesLALaerdal Million Lives FundOSOSF VenturesPOPortal Innovations+1 more

Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.

BiotechHealthtechMedical DevicesAlpharetta, US

Mark Prausnitz(Director)inCharles Deignan(Executive Officer)GNGlenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in

BoardEvgeny Zaytsev(Director)DYDerek Yoon(Director)in

Board seatCTClay ThorpCSChristy Shaffer· per SEC Form D

Co-investorsHEHEALTHCARE ROYALTY PARTNERSMOMountain Group CapitalSOSolasta VenturesHAHatteras

Healthcare-enabling research organization that embeds clinical trials into everyday care using electronic health record data.

HealthtechAustin, US

Chad Moore(President)inJPJohn Potthoff(Chief Executive Officer)inJBJacylyn Bodmer(Chief Information Officer)KFKaren Flaherty(Vice President, Finance)inASAmy Staedtler(Chief Legal Officer)inSTScott Treiber(Chief Operating Officer)in

Board seatJCJohn Crumpler· per SEC Form D

Co-investorsEXExcelerate Health VenturesNONoro-Moseley PartnersNONorwest Venture PartnersSHShumway CapitalALAlly Bridge Group

G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

BiotechResearch Triangle Park, US

Jay Strum(Executive Officer)NSNorman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)

Board seatCTClay ThorpCSChristy Shaffer· per SEC Form D

Co-investorsLULumira VenturesMOMountain Group CapitalRARA CapitalSOSolasta Ventures

Qoniq combines tailored AI analytics with expert guidance to help Medical Affairs and Scientific Affairs teams analyze large volumes of publications and datasets, surface patterns, and generate industry-standard, well-sourced scientific reports.

AI & Machine LearningBiotechHealthtechPalo Alto, US

Gregory Kostello(Executive Officer)Lana Feng(Executive Officer, Director)inSusan Shiff(Executive Officer, Director)inWilliam Dai(Director)

BoardAndrew Schwab(Director)

Board seatJohn Crumpler· per SEC Form D

Co-investorsFUFusionRERealization Capital PartnersSTSteelSky Ventures

ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology.

AI & Machine LearningDigital HealthHealthtechMental HealthSaaSFairview, US

MTMark Tuomenoksa(Co-Founder & Chief Technology Officer)inLPLauren Pierce Flickinger(Chief Executive Officer)inKate Rahimzadeh(Chief Operating Officer)inSandeep Goel(Executive Officer, Director, Promoter)

Board seatLPLauren Pierce Flickinger· per SEC Form D

Co-investorsHOHomebrewHEHealth Catalyst Capital

Pelthos Therapeutics is a biopharmaceutical company that develops and commercializes topical treatments for infectious skin conditions and parasitic infestations.

BiotechHealthtechMedical DevicesDurham, US

Mark Schoenfisch(Executive Officer, Director)Nathan Stasko(Executive Officer, Director)

BoardRobert A Ingram(Director)Sean Murphy(Director)W Kent Geer(Director)John W Palmour(Director)

Board seatRobert Ingram· per SEC Form D · $50M raise · filed Mar 2015

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical DevicesMalvern, US

Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)JMJonathan Mow(Chief Executive Officer)in

BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)

Board seatRobert IngramCTClay Thorp· per SEC Form D

Co-investorsMOMountain Group CapitalNENew Enterprise Associates (NEA)JOJohnson & Johnson Innovation – JJDC

StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.

BiotechHealthtechDurham, US

AAAravind Asokan(Director)inMAMavis Abjandje-McKenna(Director)RSRichard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)

Board seatClay ThorpMike Dial· per SEC Form D

Co-investorsPOPontifax Venture CapitalABAbingworthDEDe Novo Ventures

An R&D-driven biopharmaceutical company that uses AI to develop breakthrough medicines and vaccines focused on immune system disorders across five therapeutic areas.

AI & Machine LearningBiotechMedical DevicesCambridge, US

IMIvana Magovcevic-Liebisch(Executive Officer, Director)CVChristopher Verni(Executive Officer)inMary Thistle(Director)Evan Thackaberry(Executive Officer)Suzanne Bruhn(Director)Gerhard Koenig(Director)

Board seatClay Thorp· per SEC Form D

Co-investorsATAtlas VentureLILightstone VenturesPIPivotal Life SciencesVIVida VenturesLOLongwood Fund

Wildflower Health offers a modular suite of software and services for women's health, combining a digital patient engagement app, a national network of human health advocates and specialists, and value-based care payment model support.

Digital HealthFemTechHealthtechSan Francisco, US

LSLeah Sparks(CEO & Founder)inKim Russell(Chief Financial Officer of Issuer)in

BoardDGDan Galles(Director of Issuer)inEzra Mehlman(Director of Issuer)RSRalph Sabin(Director of Issuer)in

Board seatJohn Crumpler· per SEC Form D

Co-investorsALAllumia VenturesECEcho Health VenturesHEHealthtech Capital

410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.

HardwareHealthtechMedical DevicesDurham, US

Mark Donald Piehl(Executive Officer, Director)KCKYLE CHENET(Executive Officer, Director)in

BoardJTJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FGFRED GOLDWATER(Director)inMAYANK TANEJA(Director)in

Co-investorsBABallad VenturesCUCU Healthcare Innovation FundDUDuke Capital PartnersOSOSF VenturesWOWolfpack Investor NetworkARArboretum Ventures+1 more

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.

BiotechDeep TechHealthtechMedical DevicesDurham, US

Christopher Sims(Executive Officer)inJimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)

BoardChristopher Perkins(Director)

Co-investorsATAtlanta Technology AngelsCECentral Texas Angel NetworkCHCheckmate Capital Group LLCCOCowtown AngelsIDIDEA NCJOJohnson Venture Partners+1 more

AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.

HardwareHealthtechMedical Devices

Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)

Co-investorsARArboretum VenturesBABayMed Venture PartnersBRBroadview VenturesCACatalyst Health Ventures

Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss.

BiotechDeep TechMedical DevicesAustin, US

Co-investorsLILightstone VenturesSOSofinnova Ventures

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

SVShane V. Hegarty(Chief Scientific Officer & Co-Founder)inJSJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJIJeff Imbaro(Chief Operating Officer)inTSTiasha Shafiq(Chief of Staff)in

BoardC.Corey . Goodman(Director)inJLJonathan Leff(Director)in

Co-investorsSOSofinnova VenturesVEvenBio PartnersMRMRL Ventures FundCICivilization Ventures Management, LlcCRCreative Destruction Lab (CDL)IAIaso Ventures+8 more

Backrs provides personalized coaching and college and career planning to help students—particularly high-performing, under-resourced young people—choose schools, majors, and career paths based on real outcomes like earnings and job placement.

ConsumerEdTechImpact & Social GoodSan Francisco, US

ABAndy Bobowski(Founder)in

Co-investorsCICity Light

HealthtechBurlington, US

AAArtur Adib(Founder/CEO)inTim Wall(Director)

Co-investorsBRBreyer CapitalDUDudley FundY Y Combinator191984 Ventures Management, LlcALAltaclub VCALAltaIR Capital+6 more

Boston Immune Tech develops immunotherapies for treatment of infectious diseases and cancer.

BiotechHealthtechMedical DevicesBoston, US

Russell LaMontagne(Chief Executive Officer)inDavid Brooks(Chief Medical Officer)in

Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.

BiotechDigital HealthHealthtech

BLBarbara Lopez Kunz(Chief Executive Officer)inMCMichael Clay(Chief Operating Officer)inSMSharon Moore(Chief Medical Officer)inBPBrandon Pallott(Chief Commercial Officer)inMLMiron Lila(Chief Corporate Development Officer)inJSJohn Scott(Chief Information Officer)in

Co-investorsQIQiming Venture PartnersVIVivo Capital

Canopy Lawn Care provides science-based residential lawn care services using natural ingredients like coffee grounds, amino acids, probiotics, and sea kelp to promote soil health and reduce reliance on synthetic fertilizers and pesticides.

AgTechCleantechConsumer

Co-investorsELElevate Innovation PartnersACACME CapitalARArrington CapitalBOBorderless CapitalFEFenbushi CapitalNYNyca Partners+2 more

HealthtechChicago, US

SCShara Cohen(President and CEO)inMARIA PERRIN(Director)

BoardJBJohn Banta(Director)inTJTodd Johnson(Director)ECEmma Cartmell(Director)in

Co-investors41412 Venture FundCACartmell VenturesFCFCA Venture PartnersLOLOUD CapitalBLBlueCross BlueShield Venture PartnersCRCREATE HEALTH VENTURES+1 more

Carpe manufactures clinical-grade antiperspirant and skincare products designed to reduce underarm sweat and odor for consumers.

ConsumerDirect to ConsumerHealthtechWellness & Fitness

Co-investorsLALaunchCapital

Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials.

BiotechDigital HealthHealthtechMorrisville, US

Mark Ubert(Executive Officer)Jesse Watson(Director)Brian Carney(Director)Jeff L. Williams(Executive Officer, Director)Melissa Daniels(Director)Christopher K. Porter(Executive Officer)

Co-investorsCRCreathor VenturesOUOUP (Osage University Partners)

Clinverse was a Durham, NC-based fintech company that automated financial management for global clinical trials, including site payments, budgeting, and currency conversion via its ClinPay platform.

Durham, US

Joseph F. Trepanier(Executive Officer)M. Denis Connaghan(Executive Officer, Director)

BoardJCJohn Crumpler(Director)inAndy Strayer(Director)Kenneth B. Lee(Director)inNathaniel C. Brinn(Director)

Co-investorsEDEdison Partners

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.

BiotechDeep TechHealthtechHatfield, US

Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)BMBrian McVeigh(Executive Officer, Director)in

BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)

Co-investorsNENew Enterprise Associates (NEA)4B4BIO CapitalAMAmgen VenturesJDJDRF T1D FundNONorthpond VenturesTATakeda Ventures+1 more

Curoverse provides solutions built on Arvados, an open source computing platform for managing and processing large-scale data from terabytes to petabytes.

Cloud ComputingData & InfrastructureDeep TechBoston, US

Ward Vandewege(Executive Officer)Alexander Wait Zaranek(Director)Adam Berrey(Executive Officer, Director)

BoardMichael Dial(Director)David Martirano(Director)

Co-investorsHYHyperplane Venture Capital

Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases.

BiotechHealthtechDurham, US

Robin Hyde-DeRuyscher(Founder)inMKMoise Khayrallah(CEO)inMargaret Powell(Director)Robert Helmedag(Director)John E. Bailey, Jr.(Director)

Co-investorsRERex Health VenturesWOWolfpack Investor NetworkVEVentureSouth

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes.

Digital HealthHealthtechMedical DevicesMinneapolis, US

SPStacey Pugh(Leadership (CEO))inChris Sorli, MD, PhD(Chief Medical Officer)inKrissy Wright(Chief Financial Officer)inLian Cunningham, MD, PhD(VP Clinical Affairs)inMHMelanie Hess(Regulatory Affairs Leadership)inMCMatt Cambronne(Technical/Engineering Leadership)in

Co-investorsARArboretum VenturesINIntuitive VenturesLOLongitude CapitalLULumira Ventures

Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics.

BiotechDefense TechHealthtechMedical DevicesDurham, US

Bert Valada(President and CEO)inRichard Martin(Executive Officer)Susan Reyer(Executive Officer)Michael Galiger(Executive Officer)John Mowell(Director)Thomas Edwards(Director)

FilterEasy is an online retailer that sells home air filters directly to consumers, with a focus on delivery and subscription-based replacement.

ConsumerDirect to ConsumerE-commerceRaleigh, US

Thaddeus W. Tarkington(Executive Officer, Director)KJKevin J. Barry(Executive Officer, Director)in

BoardSDSteve Dauphin(Director)DEDavid E. Gardner(Director)inLDLister Delgado(Director)inTom Lotrecchiano(Director)

Co-investorsCOCofounders CapitalELElevate Innovation PartnersARArsenalARArsenal Growth EquityBOBonaventure CapitalIDIDEA Fund Partners+2 more

An operating system enabling real estate agents to win more business

Co-investorsELElevate Innovation Partners

GoCheck Kids offers a smartphone-based MultiScreener that combines photoscreening, visual acuity, and pure tone audiometry to screen young children for vision and hearing problems.

Digital HealthHealthtechMedical Devices

DHDavid Huang(Founder)in

Co-investorsALAloft VCFCFCA Venture PartnersMUMucker Capital

Gozio provides a mobile-first platform that helps health systems build patient-facing apps for navigating care, including indoor wayfinding and patient engagement.

Digital HealthHealthtechSaaSAtlanta, US

JTJoshua Titus(Executive Officer, Director)DKDennis Keller(Executive Officer, Director)inKLKevin Lee(Executive Officer, Director)in

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.

BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB

TDThomas Davison(Executive Officer, Director)inMCM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)

Co-investorsALAlpha Wave GlobalAMAmzak HealthARArboretum VenturesEAEarly Stage Partners, LPHEHealthQuest CapitalK5K5 Global+5 more

Improved Nature produces plant-based protein products made from sustainably sourced non-GMO soy, targeting consumers seeking healthier and more environmentally responsible food options.

FoodTechHealthtechImpact & Social GoodGarner, US

Richard R. Hawkins(President/CEO)

BoardMoshe Meidan(Manager)Ken Campbell(Manager)Sarid M. Shefet(Manager)

Co-investorsWOWolfpack Investor NetworkCOConcentric

Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.

BiotechHealthtechDurham, US

PRPatrick Roberts(Executive Officer and member of the Board of Managers.)in

BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)

Co-investorsCACape Fear BioCapitalESEshelman Ventures, LLCHAHatteras

InnAVasc develops a vascular access graft for hemodialysis, featuring self-sealing pods and puncture-resistant backplates that guide dialysis needle placement to reduce needle-injury and bleeding complications.

BiotechHardwareHealthtechMedical DevicesDurham, US

Shawn Gage(Executive Officer)Jeffrey Lawson(Executive Officer, Director)Joseph Knight(Executive Officer, Director)Roberto Duane Manson(Executive Officer)

BoardDani Bolognesi(Director)

Co-investorsDUDuke Capital Partners

InvestorFlow provides an integrated front office platform for private markets firms, connecting capital formation, deployment, asset management, and investor services workflows in real time.

AI & Machine LearningEnterprise SoftwareFintechSaaS

Chris Ashrafi(Chief Revenue Officer)in

Co-investorsAMAmbina PartnersGRGrandBanks CapitalKPKPS Capital PartnersMEMerit Capital PartnersRERelay InvestmentsSTSteelSky Ventures

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.

Deep TechHealthtechMedical DevicesRoseville, US

TKTodd Kerkow(Co-Founder, President and CEO)inMJMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)

BoardKNKirk Nielsen(Director)in

Co-investorsTRTreo Ventures, LlcVEVensana Capital

Jumo Health provides patient experience solutions for clinical trials, focusing on building patient readiness through education and behavioral systems rather than traditional recruitment.

Digital HealthHealthtech

Co-investorsEXExcelerate Health VenturesFAFalfurrias

Wilmington, US

Robert B Preville(Executive Officer, Director)Robert Kaiser(Executive Officer, Director)

BoardRandy Swartz(Director)

Co-investorsVEVentureSouth

Ladder Health provides digital health services focused on pediatric care and developmental screening, helping families navigate healthcare options for their children.

Digital HealthHealthtechBoston, US

EKElizabeth Kidderin

Co-investors2525MadisonGRGROOVE CAPITALJUJumpstart CapitalMAMairs & Power VCNINina CapitalCRCREATE HEALTH VENTURES

Lysosomal Therapeutics Inc.

BiotechCambridge, US

Dimitri Krainc(Director)Robert Carpenter(Executive Officer, Director)Cornelis Been(Executive Officer, Director)

BoardSteven Hall(Director)Carole Nuechterlein(Director)inBernard Davitian(Director)

Co-investorsSASanofi VenturesATAtlas VentureLILilly VenturesOMOmega FundsRORoche Venture Fund